The Lancet. Global healthHumansRespiratory Syncytial Virus InfectionsInfantRespiratory Syncytial Virus VaccinesGlobal Health
The path to equitable respiratory syncytial virus prevention for infants: challenges and opportunities for global implementation.
Farina L Shaaban, Rosalie W Groenendijk, Ranju Baral, Mauricio T Caballero, James E Crowe, Janet A Englund, Ignacio Esteban, Siddhivinayak Hirve, Mark Jit, Alexis M Kalergis, Ruth A Karron, Nicholas Lukacs, Federico Martinon-Torres, Asuncion Mejias, Harish Nair
Published: 202510.1016/S2214-109X(25)00379-1
Abstract
The approval for a respiratory syncytial virus (RSV) maternal vaccination programme by Gavi, The Vaccine Alliance, marks substantial progress toward equitable access, with important work still to come. Several countries, most of which are high-income…
Preview only. Read the full abstract at the source